Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annick Rousseau

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Clinical Pharmacokinetics|November 9, 2004
Modelling ciclosporin double-peak absorption profiles in the early post-transplantation periodAnnick Rousseau, Pierre Marquet
Fundamental & Clinical Pharmacology|February 7, 2003
Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugsAnnick Rousseau, Pierre Marquet
Bulletin Du Cancer|November 14, 2008
[Pharmacokinetics and therapeutic drug monitoring of anticancer agents]Pierre Marquet, Annick Rousseau
Therapeutic Drug Monitoring|January 19, 2006
Population pharmacokinetics of cyclosporine in cardiopulmonary transplant recipientsFranck Saint-Marcoux, Pierre Marquet, Annick Rousseau
Pharmacological Research|November 9, 2010
Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinantsJana Stojanova, Sophie Caillard, Annick Rousseau, et al.
Therapeutic Drug Monitoring|April 22, 2006
Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometryAurélie Prémaud, Annick Rousseau, Nicolas Picard, et al.
British Journal of Clinical Pharmacology|September 26, 2006
A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patientsNicolas Picard, Aurélie Prémaud, Annick Rousseau, et al.
Therapeutic Drug Monitoring|January 30, 2010
Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulationFranck Saint-Marcoux, Jean Debord, Nasrullah Undre, et al.
Therapeutic Drug Monitoring|December 1, 2004
Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoringAurélie Prémaud, Annick Rousseau, Yannick Le Meur, et al.
Expert Review of Anti-Infective Therapy|April 7, 2009
Ribavirin in chronic hepatitis C: past and futureVéronique Loustaud-Ratti, Annick Rousseau, Pierre Marquet, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Clinical Pharmacokinetics|November 9, 2004
Modelling ciclosporin double-peak absorption profiles in the early post-transplantation periodAnnick Rousseau, Pierre Marquet
Fundamental & Clinical Pharmacology|February 7, 2003
Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugsAnnick Rousseau, Pierre Marquet
Bulletin Du Cancer|November 14, 2008
[Pharmacokinetics and therapeutic drug monitoring of anticancer agents]Pierre Marquet, Annick Rousseau
Therapeutic Drug Monitoring|January 19, 2006
Population pharmacokinetics of cyclosporine in cardiopulmonary transplant recipientsFranck Saint-Marcoux, Pierre Marquet, Annick Rousseau
Pharmacological Research|November 9, 2010
Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinantsJana Stojanova, Sophie Caillard, Annick Rousseau, et al.
Therapeutic Drug Monitoring|April 22, 2006
Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometryAurélie Prémaud, Annick Rousseau, Nicolas Picard, et al.
British Journal of Clinical Pharmacology|September 26, 2006
A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patientsNicolas Picard, Aurélie Prémaud, Annick Rousseau, et al.
Therapeutic Drug Monitoring|January 30, 2010
Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulationFranck Saint-Marcoux, Jean Debord, Nasrullah Undre, et al.
Therapeutic Drug Monitoring|December 1, 2004
Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoringAurélie Prémaud, Annick Rousseau, Yannick Le Meur, et al.
Expert Review of Anti-Infective Therapy|April 7, 2009
Ribavirin in chronic hepatitis C: past and futureVéronique Loustaud-Ratti, Annick Rousseau, Pierre Marquet, et al.
Pageof 6